Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...
Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a ...
A member of the U.K. Parliament is calling for regulators to audit pharmaceutical companies that have made misleading ...
An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...
Moderna swung to a loss in the last three months of the year after an early launch of its updated Covid-19 vaccine shifted sales out of the fourth quarter.
granted marketing authorization for an updated formulation of Moderna’s COVID-19 mRNA vaccine Spikevax, targeting the SARS-CoV-2 variant JN.1, for individuals six months and older. See Also ...
Moderna (NASDAQ:MRNA) stock drops ~5% as its Q4 2024 results show revenue beat but earnings miss expectations. Read more here ...
1, for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals six months of age and older. Moderna is a leader in the creation of the field of mRNA medicine. Through the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results